We sat down with Globus executives to discuss their entrance into the joint replacement market, robotics’ role in orthopedic surgery and the company's future as a full-scale musculoskeletal player.
Staunch supporters of AM shed the hype and paint a picture of what it takes to find success. In this recap of an OMTEC 2019 panel, they talk market barriers, opportunities, materials and validation.
The agency has prioritized the reduction of EtO to sterilize medical devices, and is providing insights on how and why orthopedic manufacturers should consider adopting new sterilization processes.
CMS' removal of these procedures from the inpatient only list makes them eligible for coverage by Medicare in hospital outpatient and inpatient settings, effective in 2020.
LimaCorporate and Hospital for Special Surgery are set to open a 3D printing facility to produce custom complex orthopedic implants in 2020. The collaboration will be closely watched, especially as FDA, hospitals and industry engage in dialogue on the pursuit of point-of-care manufacturing.
Registration opens February 2020. Booth applications can be completed here.
Exhibitor Presentations are back for 2020!
The call for abstracts will be sent in January. Want to be sure you receive an invitation? Contact
Brad Frey.
Begin identifying your next new partner by perusing this
confirmed list of exhibitors. The exhibit floor is 80% reserved!
Stefano Bini, M.D., a knee and hip replacement surgeon and Chief Technology Officer at UCSF spoke with us about the state and future of digital technologies.
A growing extremities company grows even more, and two well-established joint replacement players collaborate globally on components for hip replacement.
Identify critical considerations for Work-In-Process Exposure vulnerabilities. A disciplined assessment of the contributors to Overall Exposure Risk supports fact-based decisions to yield repeatable, capable processes that reduce device degradation.
ATEC, NextStep Arthropedix, Nextremity Solutions and Active Implants bolstered their portfolios at year-end with products to help grow revenue in the coming year.
OEMs and suppliers can reduce cost and lead times while preserving or improving margins with numerous initiatives that don't require material or design changes. Simply commit to a cost-focused collaboration that is incorporated into the terms of a master supply or service agreement.
Stryker’s planned acquisition of Wright Medical (previously the #5 trauma player) bolsters the company’s position in trauma and puts Arthrex on the board in position #10.